Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases

被引：0
|
作者：
Maria Fasshauer
Michael Borte
Michaela Bitzenhofer
Christine Pausch
David Pittrow
Michelle Park
André Gladiator
Peter Jandus
机构：
[1] Hospital St. Georg,Hospital for Children and Adolescents
[2] Academic Teaching Hospital of the University of Leipzig,ImmunoDeficiencyCenter Leipzig (IDCL)
[3] Hospital St. Georg,Division of Allergology and Clinical Immunology, Department of Pneumology
[4] Academic Teaching Hospital of the University of Leipzig,Institute for Clinical Pharmacology
[5] University Hospital Berne (Inselspital Bern),Division of Clinical Immunology and Allergy, Department of Medicine
[6] GWT-TUD GmbH,undefined
[7] Innovation Centre Real World Evidence,undefined
[8] Technical University,undefined
[9] Takeda Development Center Americas,undefined
[10] Inc.,undefined
[11] Takeda Pharmaceuticals International AG,undefined
[12] University Hospital and Medical Faculty,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Antibody deficiency syndromes; Ig20Gly; Immunoglobulin replacement therapy; Inborn errors of immunity; Observational; Primary immunodeficiency diseases; SCIG; Subcutaneous immunoglobulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5168 / 5187
页数：19
相关论文
共 50 条
  • [21] Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases
    Hans D. Ochs
    Sudhir Gupta
    Peter Kiessling
    Uwe Nicolay
    Melvin Berger
    Journal of Clinical Immunology, 2006, 26 : 265 - 273
  • [22] Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature Review
    Dimou, Maria
    Vacca, Angelo
    Sanchez-Ramon, Silvia
    Karakulska-Prystupiuk, Ewa
    Lionikaite, Vikte
    Siffel, Csaba
    Anderson-Smits, Colin
    Kamieniak, Marta
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [23] Real-World Evaluation of Immune Globulin Subcutaneous 16.5% in the Treatment of Primary Immunodeficiency
    Langford, Jeffrey
    Herrscher, Richard
    Mehta, Samantha
    Van Anglen, Lucinda
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB72 - AB72
  • [24] Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
    Sudhir Gupta
    James DeAngelo
    Isaac Melamed
    Jolan E. Walter
    Ai-Lan Kobayashi
    Tracy Bridges
    J. Wesley Sublett
    Jonathan A. Bernstein
    Alan Koterba
    Michael Manning
    Joanna Maltese
    Sonja Hoeller
    Eva Turpel-Kantor
    Huub Kreuwel
    Roger H. Kobayashi
    Journal of Clinical Immunology, 2023, 43 : 1414 - 1425
  • [25] Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
    Gupta, Sudhir
    DeAngelo, James
    Melamed, Isaac
    Walter, Jolan E. E.
    Kobayashi, Ai-Lan
    Bridges, Tracy
    Sublett, J. Wesley
    Bernstein, Jonathan A. A.
    Koterba, Alan
    Manning, Michael
    Maltese, Joanna
    Hoeller, Sonja
    Turpel-Kantor, Eva
    Kreuwel, Huub
    Kobayashi, Roger H. H.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1414 - 1425
  • [26] Psychometric evaluation of the immunoglobulin patient experience with treatment (IgPET) in primary immunodeficiency diseases
    Coles, Theresa
    Meckley, Lisa M.
    McLeod, Lori
    Williams, Nikki
    DiBenedetti, Dana
    Devercelli, Giovanna
    QUALITY OF LIFE RESEARCH, 2018, 27 : S139 - S140
  • [27] Real-World Use of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IG) (IGHy) in Patients with Primary Immunodeficiency Disorders (PIDD)
    Rosenbach, Kevin P.
    Hughes, Stephanie
    Rozen, Leon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
  • [28] Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases
    Kobayashi, Roger H.
    Litzman, Jiri
    Rizvi, Syed
    Kreuwel, Huub
    Hoeller, Sonja
    Gupta, Sudhir
    IMMUNOTHERAPY, 2022, 14 (04) : 259 - 270
  • [29] Efficacy and Safety of Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases
    Stelmach, I.
    Bal, K.
    Sobocinska, A.
    Zaczeniuk, M.
    Podsiadlowicz-Borzecka, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S304 - S304
  • [30] Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials
    Lisa M. Meckley
    Yanyu Wu
    Diane Ito
    Todd Berner
    Barbara McCoy
    Leman Yel
    BMC Immunology, 21
12345